Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results.
第一作者:
Rita,Fazzi
第一单位:
Hematology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
作者:
主题词
成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);骨髓移植(Bone Marrow Transplantation);化学疗法, 辅助(Chemotherapy, Adjuvant);疾病恶化(Disease Progression);女(雌)性(Female);人类(Humans);白细胞介素2(Interleukin-2);意大利(Italy);男(雄)性(Male);中年人(Middle Aged);多发性骨髓瘤(Multiple Myeloma);缓解诱导(Remission Induction);时间因素(Time Factors);治疗结果(Treatment Outcome)
DOI
10.3389/fimmu.2020.573156
PMID
33613510
发布时间
2021-06-14
- 浏览0
Frontiers in immunology
573156页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文